Co-Founder, CEO and President

Chief Commercial Officer

Kura Oncology Announces Preliminary Data from Its Farnesyl Transferase Inhibitor (FTI) Programs at the 2025 European Society for Medical Oncology (ESMO) Congress

Kura Oncology management to meet with Cantor

Small Molecule Targeted Therapy Market Set to Reach $110.52 Billion by 2029

Menin Inhibitors Drug Market Report 2025: Price, Sales & Clinical Trials Insights 2024-2028 - Kura Oncology & Kyowa Kirin Progress with New Drug Applications

Associate Director/Director, Clinical Pharmacology

Kura Oncology is a clinical-stage biopharmaceutical company focused on developing precision medicines for cancer treatment. They are seeking an Associate Director/Director of Clinical Pharmacology to lead and implement nonclinical and clinical ADME strategies, working collaboratively with program teams to optimize drug development processes.

Sign up with Google

Sign in with Google